AzTrials
AzTrials

Pelvic Organ ProlapseNCT02294383

Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions

An observational study of Pelvic Organ Prolapse, run by Artann Laboratories at 2 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The clinical study includes investigation of the outcomes of surgery for biomechanical restoration of pelvic floor conditions, monitoring pelvic floor conditions under conservative treatment/management, identification and investigation changes of pelvic floor muscle contractions and their significance in… Read more about this study

Who is it for?
Ages 21 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Pelvic Organ Prolapse
How many people
138 participants
Where
2 sitesUnited States
Study dates
Aug 2014to Jan 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: The study population comprises of patients referred to a gynecologist/urogynecologist for either regular examination or with a pelvic floor organ concern.

Who may be able to join

  • No prior pelvic floor surgery, and
  • Normal pelvic floor conditions, or
  • POP Stage I affecting one or more vaginal compartment, or
  • POP Stage II affecting one or more vaginal compartment, or
  • POP Stage III affecting one or more vaginal compartment, or
  • POP Stage IV affecting one or more vaginal compartment.

Who cannot join

  • Active skin infection or ulceration within the vagina
  • Presence of a vaginal septum;
  • Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;
  • Ongoing radiation therapy for pelvic cancer;
  • Impacted stool;
  • Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus or vulvadynia;
Show all 9Show fewer
  • Severe hemorrhoids;
  • Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician;
  • Current pregnancy.

Trial locations and contacts

2 sites in 1 country.

United States2 sites
  • Institute of Female Pelvic Medicine and Reconstructive Surgery

    Allentown, Pennsylvania, 18103

  • Princeton Urogynecology

    Princeton, New Jersey, 08540

Other trials in United States

About this study

The clinical study includes investigation of the outcomes of surgery for biomechanical restoration of pelvic floor conditions, monitoring pelvic floor conditions under conservative treatment/management, identification and investigation changes of pelvic floor muscle contractions and their significance in characterization of pelvic floor conditions, assessment of tactile imaging reproducibility, including pelvic floor muscle contraction.

Keywords
Pelvic Floor Biomechanics, Tissue Elasticity, Tactile Imaging
Medical subject headings
Pelvic Organ Prolapse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02294383
Study groupRoleWhat they receive
Pre/post surgery pelvic floor assessmentNot described
Conservative treatmen monitoringNot described
Pelvic floor muscle contrictionsNot described
Imaging reproducibilityNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tissue elasticity measured as a gradient in tactile image. Unit of Measure: kPa/mm

    Measured: From 1 day to 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Nov 2014 (estimated)
  2. Study startAug 2014
  3. Primary completionJan 2016
  4. Study completionJan 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
138 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02294383
Sponsor's protocol ID
VTI05
Other IDs
R44AG034714
Status last verified
Jun 2018
First submitted
14 Nov 2014
Last updated
7 Jun 2018
Results posted
No
Data monitoring committee
No

Publications

  • Egorov V, van Raalte H, Sarvazyan AP. Vaginal tactile imaging. IEEE Trans Biomed Eng. 2010 Jul;57(7):1736-44. doi: 10.1109/TBME.2010.2045757. Epub 2010 May 17.

    PubMed 20483695
  • Egorov V, van Raalte H, Lucente V. Quantifying vaginal tissue elasticity under normal and prolapse conditions by tactile imaging. Int Urogynecol J. 2012 Apr;23(4):459-66. doi: 10.1007/s00192-011-1592-z. Epub 2011 Nov 10.

    PubMed 22072417
  • van Raalte H, Egorov V. Characterizing female pelvic floor conditions by tactile imaging. Int Urogynecol J. 2015 Apr;26(4):607-9. doi: 10.1007/s00192-014-2549-9. Epub 2014 Oct 25.

    PubMed 25344223

Questions about this trial

What is this clinical trial studying?

An observational study of Pelvic Organ Prolapse, run by Artann Laboratories at 2 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tissue elasticity measured as a gradient in tactile image. Unit of Measure: kPa/mm (time frame: From 1 day to 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02294383, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in